Back to User profile » Dr Liwei Deng
Paper published by Dr Liwei Deng:
Original Research
Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Deng L, Sun Y, Wang H, Liao C, Li D, Xu G, Yang X
Journal of Hepatocellular Carcinoma 2024, 11:29-38
Published Date: 9 January 2024